These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18319219)

  • 1. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
    Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
    Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
    Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
    Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults.
    Onat A; Hergenç G; Karabulut A; Türkmen S; Doğan Y; Uyarel H; Can G; Sansoy V
    Prev Med; 2006 Aug; 43(2):136-9. PubMed ID: 16714057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
    Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
    Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum folate is associated with coronary heart disease independently of homocysteine in Turkish men.
    Onat A; Hergenç G; Küçükdurmaz Z; Can G; Ayhan E; Bulur S
    Clin Nutr; 2008 Oct; 27(5):732-9. PubMed ID: 18694616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum total and high-density lipoprotein phospholipids: independent predictive value for cardiometabolic risk.
    Onat A; Altuğ Çakmak H; Can G; Yüksel M; Köroğlu B; Yüksel H
    Clin Nutr; 2014 Oct; 33(5):815-22. PubMed ID: 24246837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly].
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):827-31. PubMed ID: 12895332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
    Onat A
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
    Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
    Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndrome.
    Onat A; Hergenç G; Ozhan H; Kaya Z; Bulur S; Ayhan E; Can G
    Coron Artery Dis; 2008 May; 19(3):125-31. PubMed ID: 18418227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
    Athyros VG; Liberopoulos EN; Mikhailidis DP; Papageorgiou AA; Ganotakis ES; Tziomalos K; Kakafika AI; Karagiannis A; Lambropoulos S; Elisaf M
    Angiology; 2007 Dec-2008 Jan; 58(6):689-97. PubMed ID: 18216378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH; Chunawala L; Linde R; Reaven GM
    J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
    Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
    Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of a high-carbohydrate, low-fat diet on the levels of serum phospholipids and triglycerides].
    Tang H; Li ZK; Lin J; Huang X; Gan CF; Li RH; Hu W; Fang DZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):822-5. PubMed ID: 17953368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.